[MO40] Mini-Oral Session 40　Lung Cancer / Thoracic Cancer 6（Biomarker）
【E】

[MO40-5] Genomic and Transcriptomic Features of Response to Immune Checkpoint Inhibitors in Small Cell Lung Cancer

^○Hiroaki Kanemura¹, Hidetoshi Hayashi¹, Shuta Tomida², Junko Tanizaki³, Shinichiro Suzuki³, Yusuke Kawanaka³, Asuka Tsuya⁴, Yasushi Fukuda⁵, Hiroyasu Kaneda⁶, Keita Kudo⁷, Takayuki Takahama⁸, Ryosuke Imai⁹, Koji Haratani¹, Yasutaka Chiba¹⁰, Tomoyuki Otani¹¹, Akihiko Ito¹¹, Kazuko Sakai¹², Kazuto Nishio¹², Kazuhiko Nakagawa¹ (1.Department of Medical Oncology, Kindai University Faculty of Medicine, 2.Department of Biobank, Graduate School of Medicine, Dentistry, and Pharmaceutical Science, Okayama University, 3.Department of Medical Oncology, Kishiwada City Hospital, 4.Department of Medical Oncology, Izumi City General Hospital, 5.Department of Respiratory Medicine, Kurashiki Central Hospital, 6.Department of Clinical Oncology, Graduate School of Medicine, Osaka City University, 7.Department of Thoracic Medical Oncology, National Hospital Organization Osaka Minami Medical Center, 8.Department of Medical Oncology, Kindai University Nara Hospital, 9.Department of Pulmonary Medicine, Thoracic Center St. Luke's International Hospital, 10.Clinical Research Center, Kindai University Hospital, 11.Department of Pathology, Kindai University Faculty of Medicine, 12.Department of Genome Biology, Kindai University Faculty of Medicine)